Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation
- 26 June 2009
- journal article
- letter
- Published by Wiley in Movement Disorders
- Vol. 24 (12), 1852-1854
- https://doi.org/10.1002/mds.22493
Abstract
No abstract availableFunding Information
- Academical Medical Centre
- Juliana Children's Hospital
This publication has 5 references indexed in Scilit:
- Secondary social anxiety in hyperkinesiasMovement Disorders, 2008
- Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle diseaseNature Genetics, 2006
- Startle syndromesThe Lancet Neurology, 2006
- A measure of anxiety symptoms among childrenBehaviour Research and Therapy, 1998
- The Anxiety Disorders Interview Schedule for ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 1988